Physician profile
Matthew Stanich
NPI 1235464181
$2,054.20
in general payments reported to CMS, 2019-2025
7 companies · $197 in 2025
The $197 reported for 2025 was more than what 80% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $149 · 2021: $274 · 2022: $95.16 · 2024: $1,176 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $905 · Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $904.90 |
| Food and Beverage | $467.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,449.54 | 2019-2024 | |
| Edwards Lifesciences Corporation | $211.38 | 2020-2025 | Hemosphere |
| Becton, Dickinson and Company | $117.53 | 2025 | |
| La Jolla Pharmaceutical Company | $115.24 | 2019 | |
| Boston Scientific Corporation | $66.83 | 2021-2022 | |
| Abiomed | $51.47 | 2024 | Impella |
| Mindray Ds USA, INC. | $42.21 | 2025 | A7 Anesthesia System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Stanich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.